Alastair Thompson

9PUBLICATIONS
118CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Phylogeny and comparative analysisChemotherapyMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 21, 2026
Patient-Level Evaluation of Optimal Margin Width for Lumpectomy in Ductal Carcinoma In Situ: An Analysis of Patients in the National Cancer Database Special Study.

|May 12, 2026
Mammographic surveillance in breast cancer patients aged 50 years or older: a synopsis of the Mammo-50 RCT.

|Aug 13, 2025
An Annotated Biobank of Triple-Negative Breast Cancer Patient-Derived Xenografts Features Treatment-Naïve and Longitudinal Samples during Neoadjuvant Chemotherapy.

Amanda L Rinkenbaugh, Yuan Qi, Shirong Cai

|Jan 13, 2025
Conquering Overtreatment of DCIS: Lessons from PRECISION.

Proteeti Bhattacharjee, Esther H Lips, Elinor J Sawyer

|Oct 02, 2024
Targeting the Epidermal Growth Factor Receptor Pathway in Chemotherapy-Resistant Triple-Negative Breast Cancer: A Phase II Study.

Clinton Yam, Miral Patel, Holly A Hill

|May 17, 2024
Epigenetic activation of SOX11 is associated with recurrence and progression of ductal carcinoma in situ to invasive breast cancer.

Warapen Treekitkarnmongkol, Vandna Shah, Kazuharu Kai

Pageof 2

Frequent Collaborators

2 joint publications

Stavros Petrou

2 joint publications

Sarah E Lamb

2 joint publications

Ranjit Lall

2 joint publications

Sophie Rees